Koriyama Hiroshi

コオリヤマヒロシ | Koriyama Hiroshi

Affiliation and department：
Research theme for competitive and other funds (3)：

2016 - 2019 Vaccine development for renin angiotensin system
2015 - 2018 The prophylactic effect of IL-17A DNA vaccine on arthritis
2014 - 2017 Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats

Papers (38)：

Hiroshi Koriyama, Yuka Ikeda, Hironori Nakagami, Munehisa Shimamura, Shota Yoshida, Hiromi Rakugi, Ryuichi Morishita. Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice. Vaccines. 2020. 8. 1
Akiko Tenma, Hironori Nakagami, Hideki Tomioka, Makoto Sakaguchi, Ryoko Ide, Hiroshi Koriyama, Hiroki Hayashi, Munehisa Shimamura, Hiromi Rakugi, Ryuichi Morishita. AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine. FASEB bioAdvances. 2019. 1. 12. 760-772
Tomohiro Kawano, Munehisa Shimamura, Hironori Nakagami, Tatsuya Iso, Hiroshi Koriyama, Shuko Takeda, Kosuke Baba, Tsutomu Sasaki, Manabu Sakaguchi, Ryuichi Morishita, et al. Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice. Hypertension (Dallas, Tex. : 1979). 2018. 72. 6. 1355-1364
Zhengda Pang, Akifumi Kushiyama, Jiao Sun, Takako Kikuchi, Hiroki Yamazaki, Yasuhiko Iwamoto, Hiroshi Koriyama, Shota Yoshida, Munehisa Shimamura, Masayoshi Higuchi, et al. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2017. 31. 9. 4053-4063
Kouji Wakayama, Munehisa Shimamura, Jun-Ichi Suzuki, Ryo Watanabe, Hiroshi Koriyama, Hiroshi Akazawa, Hironori Nakagami, Hideki Mochizuki, Mitsuaki Isobe, Ryuichi Morishita. Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress. Stroke. 2017. 48. 5. 1362-1368

ｍore...

MISC (16)：

Hitomi Kurinami, Munehisa Shimamura, Hironori Nakagami, Hideo Shimizu, Hiroshi Koriyama, Tomohiro Kawano, Hideki Mochizuki, Ryuichi Morishita. Development of a Novel Anti-inflammatory and Anti-osteoplastic Peptide Based on De-loop and Ef-loop in Rankl for Treatment of Ischemic Stroke. STROKE. 2016. 47
郡山弘, 中神啓徳, 勝谷友宏, 楽木宏実, 森下竜一. アンジオテンシンIIワクチンによる高血圧症の新規治療法の開発. 日本高血圧学会総会プログラム・抄録集. 2015. 38回. 362-362
Hironori Nakagami, Hiroshi Koriyama, Ryuichi Morishita. Development of Therapeutic Vaccine for Angiotensin II. JOURNAL OF CARDIAC FAILURE. 2014. 20. 10. S151-S151
Hironori Nakagami, Mariana Kiomy Osako, Natsuki Yasumasa, Munehisa Shimamura, Mariko Kyutoku, Futoshi Nakagami, Hiroshi Koriyama, Hideki Tomioka, Tomohiro Katsuya, Ryuichi Morishita. Pitavastatin improves endothelial function and glucose metabolism in ovariectomized mice. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 2012. 12. 29-33
Mariko Kyutoku, Hironori Nakagami, Futoshi Nakagami, Hiroshi Koriyama, Mariana Kiomy Osako, Munehisa Shimamura, Takashi Miyake, Ryuichi Morishita. Lipoprotein(a) is a therapeutic target for cardiovascular disease. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 2012. 12. 118-121

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page